Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus

Neuropsychopharmacology

Volumn 22, Issue 1, 2000, Pages 42-51

  Fujimaki, Koichiro ^a   Morinobu, Shigeru ^a   Duman, Ronald S ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b YALE UNIVERSITY   (United States)

Author keywords

BDNF; Desipramine; Org 4428; Phosphodiesterase type 4 inhibitor; Ro 20 1724; Rolipram

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOPHILIN; DESIPRAMINE; MESSENGER RNA; ORG 4428; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; 4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DESIPRAMINE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; PHOSPHODIESTERASE INHIBITORS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; ROLIPRAM; TRANSCRIPTION, GENETIC;

EID: 0033991319     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00084-6     Document Type: Article

References (36)

1. Beavo J.A., Conti M., Heaslip R.J. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 46:1994;399-405.
2. Bertolino A., Crippa D., di Dio S., Fichte K., Musmeci G., Porro V., Rapisarda V., Sastre-Y-Hernandez M., Schratzer M. Rolipram versus imipramine in patients with major, "minor," or atypical depressive disorder. A double-blind study, double-dummy study aimed at testing a novel therapeutic approach Int Clin Psychopharmacol. 3:1988;245-253.
3. Bersudsky Y., Kotler M., Shifrin M., Belmaker R.H. A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. J Neural Transm. 103:1996;1463-1467.
4. Bishop J.E., Joshi G., Mueller G.P., Mouradian M.M. Localization of putative calcium-response regions in the rat BDNF gene. Mol Brain Res. 50:1997;154-160.
5. Bobon D., Breulet M., Gerard-Vandenhove M.-A., Guito-Goffioul F., Plomteux G., Satre-Hernandez M., Schratzer M., Troisfontaines B., von Frenckell R., Wachtel H. Is phosphodiesterase inhibitor a new mechanism of antidepressant action? Eur Arch Psychiatr Neurol Sci. 238:1988;2-6.
6. Condorelli D.F., Dell'Albani P., Mudo G., Timmusk T., Belluardo N. Expression of neurotrophins and their receptors in primary astroglial cultures. Induction by cAMP elevating agents J Neurochem. 63:1994;509-516.
7. Conti M., Nemoz G., Sette C., Vicini E. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr Rev. 16:1995;370-389.
8. Conti M., Jin S.-L.C. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol. in press:1999.
9. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;596-606.
10. Duman R.S., Vaidya V.A., Nibuya M., Morinobu S., Rydelk-Fitzgerald L. Stress, antidepressant treatments, and neurotrophic factors. Molecular and cellular mechanisms The Neuroscientist. 1:1995;351-360.
11. Eckmann F., Fichte K., Meya U., Sastre-Y-Hernandez M. Rolipram in major depression. Results of a double-blind comparative study with amitriptyline Curr Ther Res. 43:1988;291-295.
12. Fleischhacker W.W., Hinterhuber H., Bauer H., Pflug B., Berner P., Simhandl C., Wilf R., Gerlach W., Jaklitsch H., Sastre-y-Hernandez M., Schmeding-Wiegel H., Sperner-Unterweger B., Voet B., Schubert H. A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology. 26:1992;59-64.
13. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 263:1994;1618-1623.
14. Griebel G., Misslin R., Vogel E., Bourguignon J. Behavioral effects of rolipram and structurally related compounds in mice. Behavioral sedation of cAMP phosphodiesterase inhibitors Pharmacol Biochem Behav. 39:1991;321-323.
15. Hebenstreit G.F., Fellerer K., Fichte K., Fischer G., Geyer N., Meya U., Sastre-Y-Hernandez M., Schony W., Schratzer M., Soukop W. Rolipram in major depressive disorder. Results of a double-blind comparative study with imipramine Pharmacopsychiatry. 22:1989;156-160.
16. Heninger G.R., Charney D.S. Mechanisms of action of antidepressant treatments. implications for the etiology and treatment of depressive disorders Meltzer H.Y. Psychopharmacology. The Third Generation of Progress:1987;535-544 Raven, New York.
17. Kuroda Y., McEwen B.S. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Mol Brain Res. 59:1998;35-39.
18. Malison R.T., Price L.H., Nestler E.J., Heninger G.R., Duman R.S. Efficacy of papaverine addition for treatment-refractory major depression. Am J Psychiatry. 154:1997;579-580.
19. Mamonous L.A., Blue M.E., Siuciak J.A., Anthony Alter C. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 15:1994;1929-1939.
20. Martin-Iverson M.T., Todd K.G., Alter C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors. Interactions with amphetamine J Neurosci. 14:1994;1262-1270.
21. Morinobu S., Nibuya M., Duman R.S. Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology. 12:1995;221-228.
22. Nestler E.J., Terwilliger R.Z., Duman R.S. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem. 53:1989;1644-1647.
23. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF mRNA and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:1995;7539-7547.
24. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
25. O'Donnell J.M. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate. J Pharmacol Exp Ther. 264:1993;1168-1178.
26. Ozawa H., Rasenick M.M. Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem. 56:1991;330-338.
27. Przegalinski E., Bigajska K. Antidepressant properties of some phosphodiesterase inhibitors. Pol J Pharmacol Pharm. 25:1983;233-240.
28. Scott A.I., Perini A.F., Shering P.A., Whalley L.J. In-patient major depression. is rolipram as effective as amitriptyline? Eur J Clin Pharmacol. 40:1991;127-129.
29. Siuciak J.A., Lewis D., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor. Pharmacol Biochem Behav. 56:1997;131-137.
30. Siuciak J.A., Anthony Alter C., Wiegand S.J., Lindsay R.M. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res. 633:1994;326-330.
31. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress alters the express of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15:1995;1768-1777.
32. Timmusk T., Palm K., Metsis M., Reintam T., Paalmee V., Sarma M., Persson H. Multiple promoters direct tissue specific expression of the rat BDNF gene. Neuron. 10:1993;475-489.
33. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res. 28:1997;103-110.
34. Wachtel H., Schneider H.H. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology. 25:1986;1119-1126.
35. Zafra F., Lindholm D., Thoenen H. Regulation of Brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci. 12:1992;4793-4799.
36. Zafra F., Hengerer B., Thoenen H., Lindholm D. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J. 11:1990;3545-3550.